Skip to main content


New Eczema Drug Dupixent Approved by FDA

The U.S. Food and Drug Administration today approved Dupixent (dupilumab) injection to treat adults with moderate-to-severe eczema (atopic dermatitis). Dupixent is intended for patients whose eczema is not controlled adequately by topical therapies, or those for whom topical therapies are not advisable. Dupixent can be used with or without topical corticosteroids.

GlaxoSmithKline Study Shows Nucala Improves Quality of Life, Lung Function in Severe Asthma

GlaxoSmithKline plc (LSE/NYSE:GSK) today announced data demonstrating that severe asthma patients, whose disease is driven by eosinophilic inflammation, treated with first-in-class biologic Nucala® (mepolizumab) added-on to standard of care, achieved clinically and statistically significant improvements in their health-related quality of life and lung function, when compared to patients treated with placebo and standard of care. These results are from the phase IIIb MUSCA study (NCT02281318, 200

Black Children Six Times More Likely to Die of Asthma

There is no cure for asthma, but with the proper diagnosis, medication and an asthma management plan, symptoms can be controlled. When not properly controlled asthma can be deadly. A study being presented at the 2017 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting called “Where Do Children with Asthma Die? A National Perspective from 2003 to 2014” seeks to address where and which demographics of children are dying because of asthma in the United States.

Join Us for Patient Centered Outcome Research Trainings for Asthma Research

The Asthma and Allergy Foundation of America is training people affected by asthma to learn about research. If you have asthma, or are the parent or caregiver of someone with asthma, learn about the different types of research and how research can help people make future health care decisions. In this interactive training, participants will learn about: asthma management clinical research and the clinical research process patient centered outcomes research how to become involved in research...

Add Your Voice to Asthma Research

We know that everyone’s asthma is different and we would like to hear about your unique experiences about living with asthma. This research will give us insight on issues affecting quality of life and treatments for asthma. It will also help us raise awareness about living with asthma and improve our education materials. The My Life With Asthma online survey will take about 20 minutes to complete. Your identity and responses will be anonymous. After you take the survey, you can enter your...

AAFA Joins With Others to Ask for Continued Patient Protections, Health Care Access Under ACA

Asthma and allergies are among this country’s most common and costly chronic diseases. The Asthma and Allergy Foundation of America joined with 200 other organizations to urge the Trump administration to ensure that all patients have affordable health insurance coverage and access to quality care and treatment. AAFA co-signed a letter to Secretary of Health and Human Services, Tom Price, asking that he continue the patient protections of the Patient Protection and Affordable Care Act (ACA).

Xyzal Allergy 24HR Approved for Over the Counter Use

Antihistamine Offers 24-Hour Relief to Adults and Children with Seasonal and Year-Round Allergies [Press Release] BRIDGEWATER, N.J. /PRNewswire/ -- Sanofi announced that the U.S. Food and Drug Administration (FDA) approved Xyzal® Allergy 24HR as an over-the-counter (OTC) treatment for the relief of symptoms associated with seasonal and year-round allergies. Specifically, two formulations of Xyzal are now approved for OTC use – 5 mg tablets for ages 6 years and older, as well as 0.5 mg/mL...

Preparing for Natural Disasters When You Have Asthma

If you have asthma, natural disasters could affect your health in unexpected ways. Chronic medical conditions like asthma can become worse when wildfires, tornadoes, severe flooding or earthquakes occur. Asthma flare-ups during a disaster can happen because of: Allergens in the air (pollen, mold, etc.) Irritants in the air (dust, smoke) Losing access to your treatments due to evacuation Strong emotions (fear, anxiety) Now is a good time to create a disaster planning kit with your asthma in...

FDA Approves Spiriva Respimat to Treat Asthma In Children Ages 6-12

[Press Release] FDA Expands Approval of SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray for Maintenance Treatment of Asthma in Children Steroid-free SPIRIVA RESPIMAT now approved as asthma treatment for age 6 and older Supplemental New Drug Application (sNDA) approved under priority review from the FDA FDA also granted pediatric exclusivity to SPIRIVA RIDGEFIELD, Conn., Feb. 16, 2017 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and...

Brace Yourselves, Spring Is Coming

You may still see snow where you live, but don't be fooled: spring is just around the corner. If you have a pollen allergy , get ready now and start your treatment plan. Start taking allergy medicine before pollen season begins. Most allergy medicines work best when taken this way. This allows the medicine to prevent your body from releasing histamine and other chemicals that cause your symptoms. Tree pollen already elevated in Southern U.S. Map will spread northward in coming weeks. Start...